
X
AstraZeneca sells rights to cholesterol drug Crestor to Grunenthal
https://pharmaphorum.com/news/astrazeneca-sells-rights-to-cholesterol-drug-crestor-to-grunenthal/
Ironwood tears up licensing agreement after sales disappoint
AZ says migraine outside its strategic focus.
Companies’ actions discredited the industry, says PMCPA.
European Medicines Agency proactively publishes clinical study reports for first time.
AZ focused on sales target set by CEO Pascal Soriot.